WellFish hires Braceland for North America role
WellFish Tech, the aquaculture clinical biochemistry specialist, has continued its expansion by hiring Mark Braceland as its North America Director.
The company said this appointment will allow WellFish to better serve the North American market with its non-lethal health and welfare monitoring services.
Mark Braceland, originally from the west of Scotland, has experience in the discovery and commercialisation of several diagnostic products for aquaculture species, especially blood biomarkers. He will be responsible for establishing services in North America as well as building relationships with the diverse R&D and production markets over there, whilst at the same time retaining close ties with Scotland.
Brian Quinn, CEO of WellFish Tech said: “We are delighted with the appointment of Mark to this important role. Mark’s background in clinical aquatic animal health and commercial experience in the sector will greatly accelerate WellFish’s progress on this continent.”